Restarting Zepbound after pregnancy: what the science says about GLP-1 regain

What did @michlivinlife actually say?

One month after a C-section delivery of triplets, @michlivinlife announced she's restarting tirzepatide (Zepbound). She described gaining 120 pounds during pregnancy and losing 60-70 pounds immediately postpartum, putting her current weight at 256 pounds with a goal of returning to roughly 185 pounds. She also claimed that side effects from GLP-1 medications largely disappear "if you eat and do all the right things," and that tirzepatide produces a "quietness" in people with ADHD specifically. These are the claims worth examining.

For context, she previously lost 175 pounds over about four years using a combination of tirzepatide and gastric sleeve surgery. This is not someone new to weight loss medicine. That history matters when evaluating what she says.

Does the science back this up?

Partially. The ADHD-quietness claim has real signal behind it, but she overstates the certainty. The side-effect-management claim is more complicated than she makes it sound.

On the ADHD angle: there's emerging observational data suggesting GLP-1 receptor agonists may reduce impulsivity and "food noise" in ways that overlap with ADHD symptom profiles. A 2024 study by Erritzoe et al. in eClinicalMedicine found that semaglutide users self-reported reductions in compulsive behaviors and cognitive hyperactivity. But this is still early-stage research, not a replicated clinical finding. The mechanism, likely dopaminergic signaling in the nucleus accumbens, is plausible, but it has not been confirmed in randomized controlled trials specific to ADHD populations.

On side effects resolving with good habits: the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed that nausea and GI side effects are dose-dependent and often time-limited, but they are not reliably controlled by hydration or diet alone. This framing could discourage people from reporting persistent side effects to their prescriber.

What did they get wrong (or right)?

She got the general experience right. She got the mechanism oversimplified.

The claim that side effects "literally stop" if you "drink your water" and "do all the right things" is misleading. GI side effects from tirzepatide, including nausea and vomiting, are primarily driven by the drug's action on GIP and GLP-1 receptors in the gut, not by patient behavior. While eating slowly and avoiding high-fat meals can reduce severity, they do not reliably prevent side effects. Telling new users that side effects are essentially their own fault if they persist is not accurate and could lead people to dismiss real tolerability problems.

What she got right: the "food noise" description is one of the more honest characterizations of how GLP-1 medications feel to patients who respond well. The SCALE and SURMOUNT trials consistently documented appetite suppression as a central mechanism. Her description of restarting after significant weight regain during pregnancy is also clinically realistic, not fear-mongering.

• Side effects: misleading framing, real phenomenon
• ADHD quietness: plausible but overstated certainty
• Weight regain after stopping: completely consistent with clinical data

What should you actually know?

Restarting tirzepatide at one month postpartum raises real clinical questions she does not address, and anyone considering this should know them.

First, the prescribing guidance for tirzepatide (Zepbound label, Eli Lilly, 2023) does not include studied safety data for women who are breastfeeding. The drug is excreted into breast milk in animal studies. She does not mention whether she is breastfeeding, but anyone who is should discuss this explicitly with their prescriber, not follow a TikTok timeline.

Second, C-section recovery at one month postpartum involves ongoing healing of the uterine incision and abdominal fascia. Tirzepatide's appetite suppression can substantially reduce caloric and protein intake. In postpartum recovery, that matters. There is no published trial data on tirzepatide use in the immediate postpartum period specifically.

Third, the weight she lost immediately after delivery, roughly 60-70 pounds, is largely explained by delivery of the fetuses, placenta, amniotic fluid, and postpartum fluid shifts, not medication. That is normal physiology, not a head start on weight loss.

Bottom line

This creator has legitimate firsthand experience with tirzepatide and is sharing it honestly. But "do all the right things and side effects go away" is not what the clinical data shows, and the ADHD claim needs a much larger asterisk than she gives it. The postpartum timing question is the most important thing missing from this video entirely.